Abstract

Abstract

Tritrichomonas foetus, a microscopic single-celled flagellated protozoan parasite, traditionally identified as a cause of reproductive disease in cattle, has been demonstrated as an important cause of diarrhea in cats. Until recently, an effective antimicrobial treatment for feline Tritrichomonas foetus had not been identified. Since recommended dosages of antimicrobial drugs have failed in cats infected with Tritrichomonas foetus and in vitro studies have revealed multiple drug resistance, investigations continue in the effort to find an effective treatment. One particular study by Dr. Jody Gookin noted no clinicopathological abnormalities or adverse effects with the use of ronidazole, and the research concluded that ronidazole administered at 30 to 50 mg/kg orally twice daily for 2 weeks was capable of resolving diarrhea and eradicating infections of Tritrichomonas foetus in cats. Clinical use of ronidazole has revealed a reversible, possibly dose-related, neurotoxicity. Cats receiving ronidazole should be

Related Keywords

• cats
• Tritrichomonas foetus
• trichomonad infection
• protozoa
• parasites
• parasitic infection
• ronidazole
• antibiotics
• antimicrobial agent
• antiparasitic agent
• diarrhea
• adverse effects
• side effects
• drug safety
• neurotoxicity
• nystagmus
• ataxia
• behavioral disorders
• dosage forms
• dosing
• veterinary

Related Categories

• VETERINARY
• ADVERSE DRUG EVENTS
• DOSAGE FORMS/DRUG CARRIERS
• INFECTIOUS DISEASE
• NEUROLOGY